Pronethalol, a beta-adrenergic-blocking agent, has been used successfully in the treatment of supraventricular and ventricular arrhythmias (Stock and Dale, 1963; Grandjean and Rivier, 1963; Johnstone, 1964; Payne and Senfield, 1964) . Vaughan Williams and Sekiya (1963) demonstrated that ventricular fibrillation produced in guinea-pigs by the infusion of ouabain could be prevented and controlled by beta-sympathetic blockade. This finding raised the possibility of the use of beta-adrenergicblocking agents in the treatment of the arrhythmias accompanying digitalis intoxication and in the prevention and control of ventricular fibrillation. Pronethalol was associated with the occurrence of thymic tumours in experimental animals, and it has since been replaced by propranolol (Inderal; 1-isopropylamino-3-(l-naphthyloxy)propan-2-ol hydrochloride), which has the same beta-sympathetic-blocking action but a greatly increased therapeutic ratio (Hamer et al., 1964; Srivastava et al., 1964; Prichard and Gillam, 1964; Chamberlain and Howard, 1964) .
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We here report our experience in treating three patients with recurrent ventricular fibrillation, using propranolol. blood pressure of 180 mm. Hg was obtained. Digoxin was administered intravenously in a dose of 1 mg., followed by 200 mg. of procainamide. The patient did not regain full consciousness, and was agitated and irritable; 10 mg. of papaveretum was given. After transferring him to the special-care ward the blood-pressure was 170/100 mm. Hg, with regular sinus rhythm at a rate of 90 per minute. The jugular venous pressure was not elevated. Although there was some paradoxical movement of the chest, breath sounds were well heard and there were no adventitiae. Half an hour after his admission ventricular fibrillation recurred and was treated with immediate external cardiac massage and defibrillation. The patient was given 750 mg. of procainamide intravenously and a further 100 mEq of sodium bicarbonate. However, 30 minutes later ventricular flutter occurred and this was reverted with direct-current countershock at 200 watt-seconds. A further dose of 250 mg. of procainamide was administered. The electrocardiogram showed numerous bizarre ventricular ectopics with runs of ventricular tachycardia. Four more attacks of ventricular flutter progressing to ventricular fibrillation recurred despite further doses of procainamide and intravenous sodium Amytal (Fig. 2) . After the seventh episode 15 mg. of propranolol was infused slowly. After this no ventricular ectopics were noted and no further attacks of ventricular flutter or ventricular fibrillation occurred and the blood-pressure remained stable. Elective tracheostomy was performed and the patient was continued on sedation and oral propranolol 10 mg. three times a day. He was fully conscious the day after his arrest and made good progress. There were no further cardiac' complications. Peak S.G.O.T. was 168 units and the electrocardiogram showed evidence of a recent anterior myocardial infarction. When reviewed six weeks after the cardiac arrest the patient's general condition was good. There was no evidence of any cardiac decompensation and there was no chest pain.
Discussion
In three patients propranolol was effective in suppressing recurrent ventricular fibrillation after other drug therapy had failed.
Vaughan Williams (1963) Propranolol is an effective agent in controlling ventricular arrhythmias. Ventricular fibrillation is a common mode of death in patients with myocardial infarction (Robinson et al., 1965) . Propranolol may be of value as prophylaxis against ventricular fibrillation in such patients. A controlled trial of this drug in acute myocardial infarction would be of value.
Summary
We report three cases of recurrent episodes of ventricular fibrillation controlled by propranolol (Inderal) given intravenously. In one patient with acute myocardial infarction this treatment was life-saving.
Dangers of propranolol may include hypotension, particularly in patients with extensive underlying myocardial damage. In such patients care should be exercised in administering propranolol; a maximum intravenous dose of 10 mg. is recommended.
Propranolol was of value in controlling digitalis-induced ventricular fibrillation.
